Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Z0QC
|
|||
Former ID |
DNC010408
|
|||
Drug Name |
Propan-2-one O-4-ethoxyphenylcarbamoyl oxime
|
|||
Synonyms |
CHEMBL591682; propan-2-one O-4-ethoxyphenylcarbamoyl oxime; propan-2-one, O-[[(4-ethoxy-phenyl)amino]carbonyl]oxime; BDBM50309759
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H16N2O3
|
|||
Canonical SMILES |
CCOC1=CC=C(C=C1)NC(=O)ON=C(C)C
|
|||
InChI |
1S/C12H16N2O3/c1-4-16-11-7-5-10(6-8-11)13-12(15)17-14-9(2)3/h5-8H,4H2,1-3H3,(H,13,15)
|
|||
InChIKey |
HAJFSNBTGAUVST-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.